top of page

May 30, 2024
Funding decision for Collaborative Research Centre “UbiCancer” (CRC/TRR 387)
Today, the German Research Foundation (DFG) announced that the transregional CRC on functionalisation of the ubiquitin system against...


May 24, 2024
Thalidomide derivatives degrade BCL-2 by reprogramming the binding surface of CRBN
PROXIDRUGS member Xinlai Cheng and his team published their work on how thalidomide derivatives degrade BCL-2, providing important clues...

May 14, 2024
Christian Münch receives LOEWE top professorship
Professor Christian Münch has been awarded a LOEWE Top Professorship at Goethe University. The Hessian LOEWE Top Professorship programme...


Apr 17, 2024
PROXIDRUGS vice speaker Aimo Kannt receives professorship at Goethe University Frankfurt
On 1 March, Aimo Kannt took up the Professorship for Translational Drug Research at Goethe University. The professorship is a joint...


Apr 2, 2024
TACTIC project receives funding from German Cancer Aid – Speaker is PROXIDRUGS project leader Stefan Knapp
The German Cancer Aid is funding the cancer research project "Onkogene Transkription als Zielstruktur für neue Krebstherapien (TACTIC)"...

Feb 21, 2024
Targeted protein degradation via intramolecular bivalent glues
A new class of molecular glue could pave the way for a new generation of drugs to target cancers and neurodegenerative diseases. Targeted...

Dec 20, 2023
PROXIDRUGS PI Christian Münch receives Lichtenberg-Professorship at Goethe University Frankfurt
On 1 December, Christian Münch took up the Lichtenberg Endowed Professorship for Molecular Systems Medicine. His binding to Goethe...


Nov 27, 2023
Christian Münch awarded with an ERC Consolidator Grant
PROXIDRUGS project leader Christian Münch has been awarded with a Consolidator Grant of the European Research Council (ERC). The ERC...


Nov 24, 2023
Successful prolongation of CRC 1177
Today, the German Research Foundation (DFG) announced that the Collaborative Research Centre (CRC) 1177 will be funded for another four...


Nov 16, 2023
PROXIDRUGS project leaders honored as Highly Cited Researchers 2023
The PROXIDRUGS project leaders Ivan Đikić and Gerhard Hummer are both recognized as highly cited researchers in their fields on...
bottom of page